NV-WEJO-GROUP
4.1.2022 22:32:08 CET | Business Wire | Press release
Wejo Group Limited (NASDAQ: WEJO), a global leader in cloud and software analytics generated from AV, EV and connected vehicle data (CVD), today announced it is developing a breakthrough Wejo Neural EdgeTM platform that will enable intelligent handling of data from vehicles at scale, while providing incredible insights that protect privacy and empower automotive innovation. In partnership with Microsoft, Wejo will make the announcement virtually from the Microsoft Partners Pavilion at the Consumer Electronics Show in Las Vegas.
With so much rich data coming from vehicles today, latency and data storage costs are potential obstacles in harnessing and scaling the power of real-time vehicle communications - both with other vehicles and the infrastructure that is set to power Smart Cities. Leveraging our strategic partnership with Microsoft Azure and powered by Wejo’s ADEPT platform, Wejo Neural EdgeTM optimizes how this data is managed within the vehicle, further processes it at the Edge and ultimately communicates to the cloud. This process will not only reduce data overload and maximize data insights but will reduce costs for automotive manufacturers and improve manufacturing of the vehicle to provide a better driving experience – supporting safer vehicles, enabling further advancements in EV and autonomous mobility, and reducing congestion and emissions.
“When I started Wejo in 2014, I knew that the proliferation of new mobility technology would drive data to a tipping point. And we are at that point today,” said Richard Barlow, Founder & CEO, Wejo. “With today’s vehicles producing approximately 25 gigabytes of data per hour, and as vehicle technology advances adding more sensors, data filtering and neural edge processing technology is essential to reduce this overload and drive the industry forward. Partnering with Microsoft and Palantir has positioned us to address this problem today, and to look ahead at the benefits of Wejo Neural EdgeTM as a driver in the growth of autonomous mobility. “
Wejo Neural EdgeTM will filter and analyze vast amounts of AV, EV and CV data before transmitting only the essential information to the cloud. This is made possible by utilizing in-car edge processing that Wejo is developing to filter only useful and valuable CVD before it is transmitted to the cloud. The embedded software technology in combination with Microsoft Azure cloud computing platform will enable Wejo Neural EdgeTM to power automotive innovation by:
- Reducing network and storage costs for the auto manufacturers by optimising the data coming from the vehicle. Leveraging embedded software within the vehicle chipset, Wejo Neural EdgeTM is designed to intelligently choose and prioritize the data to be sent from the vehicle to the cloud.
- Utilizing machine learning algorithms to reconstruct vehicle journey and event data, Wejo Neural EdgeTM can take 20% of the data from autonomous, electric, and other connected vehicles and reconstruct it to represent 100% of the data, without any loss in data fidelity or integrity. The positive environmental impact is significant, as less data requires less storage which in turn reduces power consumption.
- Enabling Vehicle to Vehicle (V2V) and Vehicle to Infrastructure (V2X) communications. Wejo Neural EdgeTM enables the standardisation and centralisation of the data that comes from autonomous, electric and connected vehicles. Not only does this provide a key building block for communication in near real time, but it also supports communication with infrastructure services such as road signs, traffic lights and parking lots, so vehicles can easily anticipate the road ahead and optimise mobility experiences.
- Delivering a digital twin of the vehicle and cities to reshape how we view the entire product and service ecosystem related to mobility. In a simulation environment, a digital twin of the US can be constructed to simulate how vehicles in different cities need to respond and navigate without having to outlay massive infrastructure costs of physical hardware or vehicles to be able to relearn how a vehicle should behave as an AV or EV, in the Smart City, etc.
“At Wejo, we believe that digital twins will reshape everything from road safety, to insurance, advertising, after-sales and more,” said David Burns, Chief Technology Officer, Wejo. “With Wejo Neural Edge we can look at what a CV is doing a kilometer away, and then alter and change the driver experience of an AV based on the information that is coming from down the road.”
As more auto manufacturers work to harness their vehicle data, Wejo Neural EdgeTM and Wejo’s common data model will enable different manufacturer makes and models to speak the same data language, a key component supporting vehicle to vehicle communication and vehicle communications with infrastructure and services. Wejo’s continued partnership with Palantir furthers how this model can adeptly address the problems of today and inform decisions for tomorrow.
“Our ongoing partnership with Wejo is focused on the most complex and critical challenges facing the future of mobility” says Shyam Sankar, Chief Operating Officer of Palantir Technologies. “What Wejo is building atop Palantir Foundry, including their cutting-edge neural edge technology, is a testament to the depth of their vision, speed of execution, and power of combining our technologies.”
Further details about the availability of the Wejo Neural Edge Processing platform will come at a future date.
About Wejo
Wejo (NASDAQ: WEJO) is a global leader in connected vehicle data, revolutionising the way we live, work and travel by transforming and interpreting historic and real-time vehicle data. The company enables smarter mobility by organising trillions of data points from 11.9 million vehicles and more than 60 billion journeys globally, across multiple brands, makes and models, and then standardising and enhancing those streams of data on a vast scale. Wejo partners with ethical, like-minded companies and organisations to turn that data into insights that unlock value for consumers. With the most comprehensive and trusted data, information and intelligence, Wejo is creating a smarter, safer, more sustainable world for all. Founded in 2014, Wejo employs more than 250 people and has offices in Manchester in the UK and in regions where Wejo does business around the world. For more information, visit: www.wejo.com .
About Palantir
Palantir Technologies Inc. builds and deploys operating systems for the modern enterprise. Additional information is available at https://www.palantir.com .
Who dares, wins.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this release, including statements regarding the Company’s future operating results and financial position, business strategy and plans, objectives of management for future operations are forward-looking statements. These statements are based on the Company’s current expectations, assumptions, estimates and projections. These statements involve known and unknown risks, uncertainties and other important factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements are based on management's current expectations and assumptions regarding the Company’s business, the economy and other future conditions.
Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including, without limitation, those factors described in the Company’s filings with the Securities and Exchange Commission.
These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially, and potentially adversely, from those expressed or implied in the forward-looking statements. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (i) the impact of the COVID-19 pandemic on the Company’s business; (ii) the inability to obtain or maintain the listing of the Company’s common shares on the Nasdaq Stock Market following the business combination; (iii) the ability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the Company to grow and manage growth profitably, and retain its key employees; (iv) changes in applicable laws or regulations; (v) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors, and (vi) the company’s ability to maintain effective internal control over financial reporting and disclosure controls and procedures. The foregoing list of factors is not exclusive. Additional information concerning certain of these and other risk factors is contained in Wejo’s Form 10-Q for the period ended September 30, 2021 and Wejo’s most recent filings with the SEC. All readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in their expectations with respect thereto or any change in events, conditions, or circumstances on which any statement is based, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220104006003/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
